References
- Bennett JE, Dolin E, Blaser Mj. Mandell D. And Bennett’s principles and practice of infectious diseases. 9th ed. Philadelphia, PA: Elsevier; 2019.
- Pulverer G, Schütt-Gerowitt H, Schaal KP. Human cervicofacial actinomycoses: microbiological data for 1997 cases. Clin Infect Dis. 2003;37(4):490–497.
- Bonnez W, Lattimer G, Mohanraj NA, et al. Actinomyces naeslundii as an agent of pelvic actinomycosis in the presence of an intrauterine device. J Clin Microbiol. 1985;21(2):273–275.
- Eng RH, Corrado ML, Cleri D, et al. Infections caused by Actinomyces viscosus. Am J Clin Pathol. 1981;75(1):113–116.
- Chao C-T, Liao C-H, Lai C-C, et al. Liver abscess due to Actinomyces odontolyticus in an immunocompetent patient. Infection. 2011;39(1):77–79.
- Könönen E, Wade WG. Actinomyces and related organisms in human infections. Clin Microbiol Rev. 2015;28(2):419–442.
- Tietz A, Aldridge KE, Figueroa JE. Disseminated coinfection with Actinomyces graevenitzii and Mycobacterium tuberculosis: case report and review of the literature. J Clin Microbiol. 2005;43(6):3017–3022.
- Apothéloz C, Regamey C. Disseminated infection due to Actinomyces meyeri: case report and review. Clin Infect Dis. 1996;22(4):621–625.
- Steininger C, Willinger B. Resistance patterns in clinical isolates of pathogenic actinomyces species. J Antimicrob Chemother. 2016;71(2):422–427.
- Hall V, Talbot PR, Stubbs SL, et al. Identification of clinical isolates of actinomyces species by amplified 16S ribosomal DNA restriction analysis. J Clin Microbiol. 2001;39(10):3555–3562.
- Schlaberg R, Simmon KE, Fisher MA. A systematic approach for discovering novel, clinically relevant bacteria. Emerg Infect Dis. 2012;18(3):422–430.
- Tschudin-Sutter S, Frei R, Weisser M, et al. Actinobaculum schaalii - invasive pathogen or innocent bystander? A retrospective observational study. BMC Infect Dis. 2011;11:289.
- Sabbe LJ, Van De Merwe D, Schouls L, et al. Clinical spectrum of infections due to the newly described Actinomyces species A. turicensis, A. radingae, and A. europaeus. J Clin Microbiol. 1999;37(1):8–13.
- Collins MD, Pascual C. Reclassification of Actinomyces humiferus (gledhill and casida) as Cellulomonas humilata nom. corrig., comb. nov. Int J Syst Evol Microbiol. 2000;50 Pt 2:661–663.
- Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the american heart association. Circulation. 2015;132(15):1435–1486.
- Wang A, Gaca JG, Chu VH. Management considerations in infective endocarditis: a review. Jama. 2018;320(1):72–83.
- Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. Jama. 2000;283(15):2008–2012.
- Wallace BC, Small K, Brodley CE, et al. Deploying an interactive machine learning system in an evidence-based practice center: abstrackr. In: Proceedings of the ACM International Health Informatics Symposium IHI 2012. p. 819–824.
- Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–638.
- Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–926.
- Uhr N. Bacterial endocarditis: report of a case in which the cause was ACTINOMYCES bovis. Arch Intern Med (Chic)). 1939;64(1):84–90.
- Beamer P, Reinhard E, Goodof I. Vegetative endocarditis caused by higher bacteria and fungi: Review of previous cases and report of two cases with autopsies. Am Heart J. 1945;29(1):99–112.
- Blevins A, Mac Neal WJ. Actinomyces septicus from human endocarditis. Am Heart J. 1946;31:663–667.
- Mac Neal WJ, Blevins A, Duryee AW. Clinical arrest of endocardial actinomycosis after 44 million units of penicillin. Am Heart J. 1946;31:668–676.
- Wedding ES. Actinomycotic endocarditis; report of two cases with a review of the literature. Arch Intern Med (Chic)). 1947;79(2):203–227.
- Dutton WP, Inclan AP. Cardiac actinomycosis. Dis Chest. 1968;54(5):463–467.
- Gutschik E. Endocarditis caused by Actinomyces viscosus. Scand J Infect Dis. 1976;8(4):271–274.
- O'Sullivan RA, Armstrong JG, Rivers JT, et al. Pulmonary actinomycosis complicated by effusive constrictive pericarditis. Aust N Z J Med. 1991;21(6):879–880.
- Lam S, Samraj J, Rahman S, et al. Primary actinomycotic endocarditis: case report and review. Clin Infect Dis. 1993;16(4):481–485.
- Moffatt S, Ahmen AR, Forward K. First reported case of bacterial endocarditis attributable to Actinomyces meyeri. Can J Infect Dis. 1996;7(1):71–73.
- Huang KL, Beutler SM, Wang C. Endocarditis due to Actinomyces meyeri. Clin Infect Dis. 1998;27(4):909–910.
- Hamed KA. Successful treatment of primary Actinomyces viscosus endocarditis with third-generation cephalosporins. Clin Infect Dis. 1998;26(1):211–212.
- Garduño E, Rebollo M, Asencio MA, Carro J, et al. Splenic abscesses caused by Actinomyces meyeri in a patient with autoimmune hepatitis. Diagn Microbiol Infect Dis. 2000;37(3):213–214.
- Mardis JS, Many WJ. Endocarditis due to Actinomyces viscosus. South Med J. 2001;94(2):240–243.
- Westling K, Lidman C, Thalme A. Tricuspid valve endocarditis caused by a new species of actinomyces: Actinomyces funkei. Scand J Infect Dis. 2002;34(3):206–207.
- Oh S, Halven PR, Hussain N. A case of polymicrobial endocarditis caused by anaerobic organisms in an injection drug user. J Gen Intern Med. 2005;20(10):C1–2.
- Julian KG, de Flesco L, Clarke LE, et al. Actinomyces viscosus endocarditis requiring aortic valve replacement. J Infect. 2005;50(4):359–362.
- Cohen E, Bishara J, Medalion B, et al. Infective endocarditis due to Actinomyces neuii. Scand J Infect Dis. 2007;39(2):180–183.
- Jitmuang A. Primary actinomycotic endocarditis: a case report and literature review. J Med Assoc Thai. 2008;91(6):931–936.
- Grundmann S, Huebner J, Stuplich J, et al. Prosthetic valve endocarditis due to Actinomyces neuii successfully treated with antibiotic therapy. J Clin Microbiol. 2010;48(3):1008–1011.
- Adalja AA, Vergis EN. Actinomyces israelii endocarditis misidentified as “ "Diptheroids". Anaerobe. 2010;16(4):472–473.
- Mehrzad R, Sublette M, Barza M. Polymicrobial endocarditis in intravenous heroin and fentanyl abuse. J Clin Diagn Res. 2013;7(12):2981–2985.
- Garrison Morgan L, Davis AL, Poommipanit P, et al. ACTINOMYCES NAESLUNDII, a previously undocumented cause of infective endocarditis; with literary review. Am J Infect Dis. 2014;10(3):132–136.
- Cortes CD, Urban C, Turett G. Actinomyces naeslundii: an uncommon cause of endocarditis. Case Rep Infect Dis. 2015;2015:602462.
- Kottam A, Kaur R, Bhandare D, et al. Actinomycotic endocarditis of the eustachian valve: a rare case and a review of the literature. Tex Heart Inst J. 2015;42(1):44–49.
- Miranda WR, Connolly HM, DeSimone DC, et al. Infective endocarditis involving the pulmonary Valve. Am J Cardiol. 2015;116(12):1928–1931.
- Toom S, Xu Y. Hemolytic anemia due to native valve subacute endocarditis with Actinomyces israelii infection. Clin Case Rep. 2018;6(2):376–379.
- Yang W-T, Grant M. Actinomyces neuii: a case report of a rare cause of acute infective endocarditis and literature review. BMC Infect Dis. 2019;19(1):511.
- Phichaphop C, Apiwattanakul N, Wanitkun S, et al. Bacterial endocarditis caused by Actinomyces oris: first reported case and literature Review. J Investig Med High Impact Case Rep. 2020;8:2324709620910645.
- Patel K, MacDonald M, Hmoud H, et al. Aortic valve endocarditis by Actinomyces odontolyticus and Gemella morbillorum oral pathogens. IDCases. 2021;24:e01079.
- Farah Khoury M, Perek S, Raz-Pasteur A. Implantable cardioverter defibrillator related Actinomyces Odontolyticus endocarditis and bacteremia-First reported case. IDCases. 2021;25:e01228.
- Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882–893.
- Morpeth S, Murdoch D, Cabell CH, et al. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med. 2007;147(12):829–835.
- Cresti A, Chiavarelli M, Scalese M, et al. Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovasc Diagn Ther. 2017;7(1):27–35.
- Papakonstantinou PE, Samonis G, Andrianaki AM, et al. Epidemiology, microbiological and clinical features, treatment, and outcomes of infective endocarditis in Crete, Greece. Infect Chemother. 2018;50(1):21–28.
- Giannitsioti E, Skiadas I, Antoniadou A, et al. Nosocomial vs. community-acquired infective endocarditis in Greece: changing epidemiological profile and mortality risk. Clin Microbiol Infect. 2007;13(8):763–769.
- Smith AJ, Hall V, Thakker B, et al. Antimicrobial susceptibility testing of actinomyces species with 12 antimicrobial agents. J Antimicrob Chemother. 2005;56(2):407–409.
- Barberis C, Budia M, Palombarani S, et al. Antimicrobial susceptibility of clinical isolates of actinomyces and related genera reveals an unusual clindamycin resistance among Actinomyces urogenitalis strains. J Glob Antimicrob Resist. 2017;8:115–120.
- Ioannou P, Mavrikaki V, Kofteridis DP. Infective endocarditis by Acinetobacter species: a systematic review. J Chemother. 2021;33(4):203–215.